✦ LIBER ✦

Comparison of the immunohistochemical expression of EGFR, c-erbB2 and p53 protein between primary and recurrent breast cancer

✍ Scribed by Shinichi Tsutsui; Shinji Ohno; Shigeru Murakami; Akemi Kataoka; Junko Kinoshita; Yoichi Hachitanda

Publisher: Springer Japan
Year: 2002
Tongue: English
Weight: 638 KB
Volume: 9
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02967575

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

c-erbB-2 protein overexpression and p53

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

✍ Shimizu, Chikako; Fukutomi, Takashi; Tsuda, Hitoshi; Akashi-Tanaka, Sadako; Wata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Background and Objectives: We investigated whether expression levels of c-erbB-2 and p53 proteins in breast cancer tissues differ in primary and metastatic lesions. Methods: Immunohistochemical staining or sandwich enzyme immunoassay was used to determine expression levels of c-erbB-2 and p53 protei

PROGNOSTIC SIGNIFICANCE OF THE CO-EXPRES

PROGNOSTIC SIGNIFICANCE OF THE CO-EXPRESSION OF p53 AND c-erbB-2 PROTEINS IN BREAST CANCER

✍ NAKOPOULOU, LYDIA L.; ALEXIADOU, ANASTASIA; THEODOROPOULOS, GEORGE E.; LAZARIS, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 814 KB

The immunohistochemical expression of p53 and c-erbB-2 gene proteins was examined in a series of 130 breast adenocarcinomas. This study intended to investigate whether the frequency of the altered expression of the tumour suppressor gene p53 and the overexpression of the oncogene c-erbB-2 in breast

Expression of c-erbB2 and p53 protein is

Expression of c-erbB2 and p53 protein is similar in breast cancer from British and Japanese women

✍ William J. Merchant; Rosemary R. Millis; Paul Smith,; Murid A. Chaudary; Diana M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 93 KB 👁 2 views

Expression of EGFR, C-erbB-2 proteins in

Expression of EGFR, C-erbB-2 proteins in breast cancer and their relation with micrometastasis in bone marrow

✍ Wu Zhengyan; Zheng Wei 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 301 KB

Expression of Survivin, Mutant p53 and C

Expression of Survivin, Mutant p53 and C-erbB-2 in Breast Cancer and Its Clinical Significance

✍ Huihua XIONG; Shiying YU; Shu XIA; Liang ZHUANG 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 113 KB

Abnormal expression of four novel molecu

Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein

✍ Han, Sehwan; Yun, Ik-Jin; Noh, Dong-Young; Choe, Kuk-Jin; Song, Sang-Yong; Chi, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

## Background: In view of the cumulative results to date, p53, nm23, erbb-2, and cathepsin d are the most promising investigational prognostic factors in breast cancer. ## Objectives: The clinical utility of these molecular markers to predict recurrence was evaluated. ## Methods: Archival patho